Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -0.77
- Piotroski Score 3.00
- Grade Buy
- Symbol (ATEC)
- Company Alphatec Holdings, Inc.
- Price $10.16
- Changes Percentage (-0.49%)
- Change -$0.05
- Day Low $9.97
- Day High $10.40
- Year High $17.34
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/25/2025
- Fiscal Year End N/A
- Average Stock Price Target $19.00
- High Stock Price Target $23.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.48
- Trailing P/E Ratio -6.95
- Forward P/E Ratio -6.95
- P/E Growth -6.95
- Net Income $-186,638,000
Income Statement
Quarterly
Annual
Latest News of ATEC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Stratec SE's (ETR:SBS) Intrinsic Value Is Potentially 80% Above Its Share Price
The analyst's price target for SBS is 26% lower than estimated fair value. A DCF model is used to evaluate Stratec SE's share price and intrinsic value based on future cash flows....
By Yahoo! Finance | 1 week ago -
Duratec Limited's (ASX:DUR) top owners are individual investors with 41% stake, while 31% is held by insiders
Individual investors have significant control over Duratec Limited, holding a 41% stake. Insiders own 31%, while institutions and hedge funds are not major shareholders. Top 5 shareholders control ove...
By Yahoo! Finance | 1 week ago -
LanzaTech Global Inc (LNZA) Q3 2024 Earnings Call Highlights: Navigating Challenges and ...
Dr. Holmgren and Geoff Trukenbrod discuss cost-saving initiatives impacting financials amid rising cash costs. LanzaTech's new business model involves partnering with infrastructure investors to fund ...
By Yahoo! Finance | 1 week ago
